Skip to main navigation Skip to search Skip to main content

Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95.

  • A Moricke
  • , A Reiter
  • , M Zimmermann
  • , H Gadner
  • , M Stanulla
  • , M Dordelmann
  • , L Loning
  • , R Beier
  • , WD Ludwig
  • , R Ratei
  • , J Harbott
  • , J Boos
  • , G Mann
  • , F Niggli
  • , A Feldges
  • , G Henze
  • , K Welte
  • , JD Beck
  • , T Klingebiel
  • , C Niemeyer
  • F Zintl, U Bode, Ernst-Christian Urban, H Wehinger, D Niethammer, H Riehm, M Schrappe

Research output: Contribution to journalResearch article

463 Citations (Web of Science)
Original languageEnglish
JournalBlood
DOIs
Publication statusPublished - 2008

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Branches of science

  • 305 Other Human Medicine, Health Sciences
  • 302 Clinical Medicine

Research Fields

  • Cancer Research

Cite this